Made Scientific Establishes Princeton, New Jersey, Manufacturing-Headquarters Operations
08/18/2025
The company’s new 60,000-square-foot GMP manufacturing facility and headquarters features five (5) ISO 7 / Grade B cleanrooms, in-house quality control labs, and dedicated process and analytical development capabilities.
"Today is more than a ribbon cutting. It is a clear signal of our commitment to this incredible industry and to this region," said Syed T. Husain, Chairman and CEO of Made Scientific. "This facility is a testament to our dedication to supporting the next generation of cell therapy innovators for clinical-to-commercial manufacturing, all under one roof. With a globally compliant infrastructure, high-throughput GMP capacity, and a world-class team built for precision and speed, we are here to help our partners bring transformative therapies to patients with confidence and efficiency."
Made Scientific specializes in developing, manufacturing, and releasing autologous and allogeneic cell therapy products for early- to mid-stage clinical trials. The company provides a range of services, including process and analytical development, GMP manufacturing, and quality control testing.
"Made Scientific's investment in Plainsboro Township is a testament to how New Jersey continues to lead the nation in life sciences and advanced biomanufacturing," noted Governor Phil Murphy. "Investing in this new facility creates good-paying, high-quality jobs for New Jerseyans. We are proud of companies like Made Scientific that are fueling the advancement of life-saving therapies and driving our innovation economy forward."
Project Announcements
Canada-Based Dainty Foods Plans Batavia Township, Ohio, Manufacturing Operations
03/08/2026
AeroVironment Expands Albuquerque, New Mexico, Manufacturing Operations
03/08/2026
First Quality Home Care Products Plans Archbold, Ohio, Production Facility
03/08/2026
PPG Expands Delaware, Ohio, Manufacturing Operations
03/08/2026
J.M. Smucker Company Expands Topeka, Kansas, Operations
03/05/2026
Novartis Gene Therapies Plans Denton, Texas, Operations
03/04/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
The New Industrial Revolution in Biotech
Q4 2025
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
Strategic Industries at the Crossroads: Defense, Aerospace, and Maritime Enter 2026
Q1 2026